1. A tissue product comprising a fibrous substrate material and a lubricating formulation, the lubricating formulation being present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 30% (by weight of the dry tissue) and comprising from about 10% (by total weight of the formulation) to about 89% (by total weight of the formulation) of an emollient, from about 10% (by total weight of the formulation) to about 50% (by total weight of the formulation) of a structurant, and from about 0.1% (by total weight of the formulation) to about 40% (by total weight of the forulation) of a rheology enhancer, wherein the rheology enhancer is selected from the group consisting of ethylenepropylenestyrene copolymers alone or in combination with mineral oil or petrolatum; butyleneethylenestyrene copolymers alone or in combination with mineral oil or petrolatum; mineral oil and styrene; and combinations thereof.
2. The tissue product as set forth in claim 1 wherein the lubricating formulation is present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 20% (by weight of the dry tissue).
3. The tissue product as set forth in claim 1 wherein the lubricating formulation is present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 10% (by weight of the dry tissue).
4. The tissue product as set forth in claim 1 wherein the emollient is present in an amount of from about 30% (by total weight of the formulation) to about 80% (by total weight of the formulation).
5. The tissue product as set forth in claim 1 wherein the emollient is present in an amount of from about 60% (by total weight of the formulation) to about 80% (by total weight of the formulation).
6. The tissue product as set forth in claim 1 wherein the structurant is present in an amount of from about 20% (by total weight of the formulation) to about 40% (by total weight of the formulation).
7. The tissue product as set forth in claim 1 wherein the rheology enhancer is present in an amount of from about 0.5% (by total weight of the formulation) to about 30% (by total weight of the formulation).
8. The tissue product as set forth in claim 1 wherein the rheology enhancer is present in an amount of from about 1% (by total weight of the formulation) to about 25% (by total weight of the formulation).
9. The tissue product as set forth in claim 1 wherein the lubricating formulation has a melt point viscosity of from about 5000 cPs to about 1,000,000 cPs.
10. The tissue product as set forth in claim 1 wherein the lubricating formulation has a melt point viscosity of from about 50,000 cPs to about 800,000 cPs.
11. The tissue product as set forth in claim 1 wherein the lubricating formulation has a melt point viscosity of from about 100,000 cPs to about 500,000 cPs.
12. The tissue product as set forth in claim 1 wherein the lubricating formulation has a process temperature viscosity of from about 50 cPs to about 50,000 cPs.
13. The tissue product as set forth in claim 1 wherein the lubricating formulation has a process temperature viscosity of from about 75 cPs to about 10,000 cPs.
14. The tissue product as set forth in claim 1 wherein the lubricating formulation has a process temperature viscosity of from about 80 cPs to about 5,000 cPs.
15. The tissue product as set forth in claim 1 wherein the lubricating formulation has a penetration hardness of from about 40 to about 140.
16. The tissue product as set forth in claim 1 wherein the lubricating formulation has a penetration hardness of from about 60 to about 120.
17. The tissue product as set forth in claim 1 further comprising a hydrophilic surfactant.
18. The tissue product as set forth in claim 1 wherein the lubricating formulation further comprises an additional ingredient selected from the group consisting of antifoaming agents, antimicrobial actives, antivirul actives, antifungal actives, antiseptic actives, antioxidants, humectants, cosmetic astringents, drug astringents, biological additives, colorants, deodorants, film formers, fragrances, lubricants, natural moisturizing agents, skin conditioning agents, skin exfoliating agents, skin protectants, solvents, hydrophilic surfactants, and UV absorbers.
19. The tissue product as set forth in claim 1 wherein emollient is selected from the group consisting of petrolatum, mineral oil, mineral jelly, isoparaffins, vegetable oils, avocado oil, borage oil, canola oil, castor oil, chamomile, coconut oil, corn oil, cottonseed oil, evening primrose oil, safflower oil, sunflower oil, soybean oil, sweet almond, and the like, lanolin, partially hydrogenated vegetable oils, polydimethylsiloxanes, methicone, cyclomethicone, dimethicone, dimethiconol, trimethicone, organo-siloxanes, silicone elastomer, gums, resins, fatty acid esters (esters of C6-C28 fatty acids and C6-C28 fatty alcohols), glyceryl esters and derivatives, fatty acid ester ethoxylates, alkyl ethoxylates, C12-C28 fatty alcohols, C12-C28 fatty acids, C12-C28 fatty alcohol ethers, Guerbet alcohols, Guerbet Acids, Guerbet Esters, and combinations thereof.
20. The tissue product as set forth in claim 1 wherein the structurant has a melting point of from about 45\xb0 C. to about 85\xb0 C.
21. The tissue product as set forth in claim 1 wherein the structurant is selected from the group consisting of animal waxes, vegetable waxes, mineral waxes, synthetic waxes, polymers, bayberry wax, beeswax, stearyl dimethicone, stearyl trimethicone, C20-C22 dimethicone, C20-C22 trimethicone, C24-C28 dimethicone, C20-C22 trimethicone, C30 alkyl dimethicone, candelilla wax, carnauba, ceresin, cetyl esters, stearyl benzoate, behenyl benzoate, esparto, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated jojoba wax, hydrogenated microcrystalline wax, hydrogenated rice bran wax, japan wax, jojoba buffer, jojoba esters, jojoba wax, lanolin wax, microcrystalline wax, mink wax, motan acid wax, motan wax, ouricury wax, ozokerite parrafin, PEG-6 beeswax, PEG-8 beeswax, rezowax, rice bran wax, shellac wax, spent grain wax, spermaceti wax, synthetic spermaceti wax, synthetic beeswax, synthetic candelilla wax, synthetic carnuba wax, synthetic japan wax, synthetic jojoba wax, C14-C28 fatty acid ethoxylates and C14-C28 fatty ethers, C14-C28 fatty alcohols, C14-C28 fatty acids, polyethylene, oxidized polyethylene, ethylene-alpha olefin copolymers, ethylene homopolymers, C18-C45 olefins, poly alpha olefins, hydrogenated vegetable oils, polyhydroxy fatty acid esters, polyhydroxy fatty acid amides, ethoxylated fatty alcohols and esters of C12-C28 fatty acids, and C12-C28 fatty alcohols, and combinations thereof.
22. The tissue product as set forth in claim 1 wherein the lubricating formulation is introduced onto the tissue by a method selected from the group consisting of spraying, slot coating, gravure coating, flexigraphic coating, ink jet printing, melt blown coating, and combinations thereof.
23. The tissue product as set forth in claim 1 wherein the tissue product is a facial tissue.
24. The tissue product as set forth in claim 1 wherein the tissue product is a bath tissue.
25. The tissue product as set forth in claim 1 wherein the tissue product is a paper towel.
26. The tissue product as set forth in claim 1 wherein the tissue product is a napkin.
27. The tissue product as set forth in claim 1 wherein the tissue product is a single-ply tissue product.
28. The tissue product as set forth in claim 1 wherein the tissue product is a multi-ply tissue product.
29. A tissue product comprising a fibrous substrate material and a lubricating formulation, the lubricating formulation being present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 30% (by weight of the dry tissue) and comprising from about 10% (by total weight of the formulation) to about 89% (by total weight of the formulation) of an emollient, from about 10% (by total weight of the formulation) to about 50% (by total weight of the formulation) of a structurant, and from about 0.1% (by total weight of the formulation) to about 40% (by total weight of the formulation) of a rheology enhancer, wherein the lubricating formulation has a melt point viscosity of from about 5000 cPs to about 1,000,000 cPs and a process temperature viscosity of from about 50 cPs to about 50,000 cPs, wherein the rheology enhancer is selected from the group consisting of ethylenepropylenestyrene copolymers alone or in combination with mineral oil or petrolatum; butyleneethylenestyrene copolymers alone or in combination with mineral oil or petrolatum; mineral oil and styrene; and combinations thereof.
30. The tissue product as set forth in claim 29 wherein the lubricating formulation is present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 20% (by weight of the dry tissue).
31. The tissue product as set forth in claim 29 wherein the lubricating formulation is present on the tissue product in an amount of from about 1% (by weight of the dry tissue) to about 10% (by weight of the dry tissue).
32. The tissue product as set forth in claim 29 wherein the emollient is present in an amount of from about 30% (by total weight of the formulation) to about 80% (by total weight of the formulation).
33. The tissue product as set forth in claim 29 wherein the emollient is present in an amount of from about 60% (by total weight of the formulation) to about 80% (by total weight of the formulation).
34. The tissue product as set forth in claim 29 wherein the structurant is present in an amount of from about 20% (by total weight of the formulation) to about 40% (by total weight of the formulation).
35. The tissue product as set forth in claim 29 wherein the rheology enhancer is present in an amount of from about 0.5% (by total weight of the formulation) to about 30% (by total weight of the formulation).
36. The tissue product as set forth in claim 29 wherein the rheology enhancer is present in an amount of from about 1% (by total weight of the formulation) to about 25% (by total weight of the formulation).
37. The tissue product as set forth in claim 29 wherein the melt point viscosity is from about 50,000 cPs to about 800,000 cPs.
38. The tissue product as set forth in claim 29 wherein the melt point viscosity is from about 100,000 cPs to about 500,000 cPs.
39. The tissue product as set forth in claim 29 wherein the process temperature viscosity is from about 75 cPs to about 10,000 cPs.
40. The tissue product as set forth in claim 29 wherein the process temperature viscosity is from about 80 cPs to about 5,000 cPs.
41. The tissue product as set forth in claim 29 wherein the lubricating formulation has a penetration hardness of from about 40 to about 140.
42. The tissue product as set forth in claim 29 wherein the lubricating formulation has a penetration hardness of from about 60 to about 120.
43. The tissue product as set forth in claim 29 further comprising a hydrophilic surfactant.
44. The tissue product as set forth in claim 29 wherein emollient is selected from the group consisting of petrolatum, mineral oil, mineral jelly, isoparaffins, vegetable oils, avocado oil, borage oil, canola oil, castor oil, chamomile, coconut oil, corn oil, cottonseed oil, evening primrose oil, safflower oil, sunflower oil, soybean oil, sweet almond, and the like, lanolin, partially hydrogenated vegetable oils, polydimethylsiloxanes, methicone, cyclomethicone, dimethicone, dimethiconol, trimethicone, organo-siloxanes , silicone elastomer, gums, resins, fatty acid esters (esters of C6-C28 fatty acids and C6-C28 fatty alcohols), glyceryl esters and derivatives, fatty acid ester ethoxylates, alkyl ethoxylates, C12-C28 fatty alcohols, C12-C28 fatty acids, C12-C28 fatty alcohol ethers, Guerbet alcohols, Guerbet Acids, Guerbet Esters, and combinations thereof.
45. The tissue product as set forth in claim 29 wherein the structurant has a melting point of from about 45\xb0 C. to about 85\xb0 C.
46. The tissue product as set forth in claim 29 wherein the structurant is selected from the group consisting of animal waxes, vegetable waxes, mineral waxes, synthetic waxes, polymers, bayberry wax, beeswax, stearyl dimethicone, stearyl trimethicone, C20-C22 dimethicone, C20-C22 trimethicone, C24-C28 dimethicone, C20-C22 trimethicone, C30 alkyl dimethicone, candelilla wax, carnauba, ceresin, cetyl esters, stearyl benzoate, behenyl benzoate, esparto, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated jojoba wax, hydrogenated microcrystalline wax, hydrogenated rice bran wax, japan wax, jojoba buffer, jojoba esters, jojoba wax, lanolin wax, microcrystalline wax, mink wax, motan acide wax, motan wax, ouricury wax, ozokerite parrafin, PEG-6 beeswax, PEG-8 beeswax, rezowax, rice bran wax, shellac wax, spent grain wax, spermaceti wax, synthetic spermaceti wax, synthetic beeswax, synthetic candelilla wax, synthetic carnuba wax, synthetic japan wax, synthetic jojoba wax, C14-C28 fatty acid ethoxylates and C14-C28 fatty ethers, C14-C28 fatty alcohols, C14-C28 fatty acids, polyethylene, oxidized polyethylene, ethylene-alpha olefin copolymers, ethylene homopolymers, C18-C45 olefins, poly alpha olefins , hydrogenated vegetable oils, polyhydroxy fatty acid esters, polyhydroxy fatty acid amides, ethoxylated fatty alcohols and esters of C12-C28 fatty acids, and C12-C28 fatty alcohols, and combinations thereof.
47. The tissue product as set forth in claim 29 wherein the lubricating formulation further comprises an additional ingredient selected from the group consisting of antifoaming agents, antivirul actives, antimicrobial actives, antifungal actives, antiseptic actives, antioxidants, cosmetic astringents, drug astringents, biological additives, colorants, deodorants, film formers, fragrances, lubricants, natural moisturizing agents, skin conditioning agents, skin exfoliating agents, skin protectants, solvents, hydrophilic surfactants, and UV absorbers.
48. The tissue product as set forth in claim 29 wherein the lubricating formulation is introduced onto the tissue by a method selected from the group consisting of spraying, slot coating, gravure coating, ink jet printing, flexi graphic coating, melt blown coating, and combinations thereof.
49. The tissue product as set forth in claim 29 wherein the tissue product is a facial tissue.
50. The tissue product as set forth in claim 29 wherein the tissue product is a bath tissue.
51. The tissue product as set forth in claim 29 wherein the tissue product is a paper towel.
52. The tissue product as set forth in claim 29 wherein the tissue product is a napkin.
53. The tissue product as set forth in claim 29 wherein the tissue product is a single-ply tissue product.
54. The tissue product as set forth in claim 29 wherein the tissue product is a multi-ply tissue product.
55. A method of manufacturing a facial tissue comprising introducing a lubricating formulation onto a tissue substrate, the lubricating formulation being present on the tissue substrate in an amount of from about 1% (by weight of the dry tissue) to about 30% (by weight of the dry tissue) and comprising from about 10% (by total weight of the formulation) to about 89% (by total weight of the formulation) of an emollient, from about 10% (by total weight of the formulation) to about 50% (by total weight of the formulation) of a structurant, and from about 0.1% (by total weight of the formulation) to about 40% (by total weight of the formulation) of a rheology enhancer, wherein the lubricating formulation has a melt point viscosity of from about 5000 cPs to about 1,000,000 cPs and a process temperature viscosity of from about 50 cPs to about 50,000 cPs, wherein the rheology enhancer is selected from the group consisting of ethylenepropylenestyrene copolymers alone or in combination with mineral oil or petrolatum; butyleneethylenestyrene copolymers alone or in combination with mineral oil or petrolatum; mineral oil and styrene; and combinations thereof.
56. The method as set forth in claim 55 wherein the emollient is present in an amount of from about 30% (by total weight of the formulation) to about 80% (by total weight of the formulation).
57. The method as set forth in claim 55 wherein the emollient is present in an amount of from about 60% (by total weight of the formulation) to about 80% (by total weight of the formulation).
58. The method as set forth in claim 55 wherein the structurant is present in an amount of from about 20% (by total weight of the formulation) to about 40% (by total weight of the formulation).
59. The method as set forth in claim 55 wherein the rheology enhancer is present in an amount of from about 0.5% (by total weight of the formulation) to about 30% (by total weight of the formulation).
60. The method as set forth in claim 55 wherein the rheology enhancer is present in an amount of from about 1% (by total weight of the formulation) to about 25% (by total weight of the formulation).
61. The method as set forth in claim 55 wherein the lubricating formulation is introduced onto the tissue substrate by a method selected from the group consisting of spraying, ink jet printing, slot coating, gravure coating, flexi-graphic coating, melt blown coating, and combinations thereof.
62. The tissue product as set forth in claim 1 wherein the rheology enhancer is selected from the group consisting of mineral oil and ethylenepropylenestyrene copolymers; mineral oil and butyleneethylenestyrene copolymers; mineral oil and styrene; and combinations thereof.
63. The tissue product as set forth in claim 29 wherein the rheology enhancer is selected from the group consisting of mineral oil and ethylenepropylenestyrene copolymers; mineral oil and butyleneethylenestyrene copolymers; mineral oil and styrene; and combinations thereof.
64. The method as set forth in claim 55 wherein the rheology enhancer is selected from the group consisting of mineral oil and ethylenepropylenestyrene copolymers; mineral oil and butyleneethylenestyrene copolymers; mineral oil and styrene; and combinations thereof.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A case for displaying food product in a product display area, the case comprising:
a base including a front portion and a rear portion;
an upper case frame coupled to the rear portion and extending partially above the product display area; and
a glass member including a lower portion coupled to the front portion, and an upper portion coupled to the upper case frame, the glass member defining a curved profile when viewed in a horizontal cross-section, and the glass member defining a straight profile when viewed in a vertical cross-section.
2. The case of claim 1, further comprising a clamp coupled to the upper portion of the glass member and a hinge pivotally coupled to the clamp and the upper case frame.
3. The case of claim 2, wherein the clamp is bent to match a curvature of the upper portion of the glass member.
4. The case of claim 1, wherein the case is defined by a wedge-style shape, and wherein the case includes one of an inside wedge-style case and an outside wedge-style case.
5. The case of claim 4, wherein the glass member is curved to match a curvature defined by the wedge-style case.
6. The case of claim 4, wherein each of the inside wedge-style case and the outside wedge-style case extends through an angle of approximately 45 degrees.
7. The case of claim 1, wherein the glass member includes a conically-shaped glass pane as if cut from a cone pointing in a downward direction.
8. The case of claim 1, wherein the glass member includes a conically-shaped glass pane as if cut from a cone pointing in an upward direction.
9. The case of claim 1, wherein the glass member defining a straight profile in a vertical cross-section is configured to mate with a straight glass member of a straight case positioned adjacent the case.
10. The case of claim 1, wherein the straight profile of the glass member defines an axis and wherein the axis defines an angle relative to a vertical axis between about 25 degrees and about 45 degrees.
11. A glass member configured for installation on a display case that includes a front portion of an upper case frame, the glass member comprising:
a glass pane including a curved lower portion configured to couple to the front portion, and a curved upper portion configured for pivotal attachment to the upper case frame;
wherein the glass pane defines a curved profile in a horizontal cross-section, and a straight profile in a vertical cross-section.
12. The glass member of claim 11, wherein the glass pane is conically-shaped as if cut from a cone pointing in a downward direction.
13. The glass member of claim 11, wherein the glass pane is conically-shaped as if cut from a cone pointing in an upward direction.
14. The glass member of claim 11, wherein the glass pane is configured to mate with a straight glass member of an adjacent straight display case.
15. A clamp configured for installation on a wedge-style display case to couple a glass member to the display case, the display case including an upper case frame, the clamp comprising:
a base including a first surface, the base configured to couple to the upper case frame;
a top portion spaced apart from the base and including a second surface;
a back wall coupled to the base and the top portion such that the first surface, the second surface, and the back wall define a slot configured to receive a portion of the glass member along a clamping axis, the clamping axis and a vertical axis cooperating to define a clamping angle for the glass member between about 25 degrees and about 45 degrees.
16. The clamp of claim 15, wherein the clamping angle is between about 30 degrees and about 40 degrees.
17. The clamp of claim 15, wherein a wedge is configured to be positioned at least partially within the slot to partially secure the glass member.
18. The clamp of claim 15, wherein the second surface includes ridges configured to partially secure the glass member in the slot.
19. The clamp of claim 15, wherein the base defines a curved profile to substantially correspond to the curvature of the wedge-style display case.
20. The clamp of claim 15, wherein the base is configured to attach to a hinge of the display case to pivotally couple the glass member to the case.
21. A method of converting a case having a spherical glass member to a case having a conically-shaped glass member, the method comprising:
providing a case including a hinge, a first clamp attached to the hinge, and a spherical glass member coupled to the first clamp;
removing the spherical glass member from the first clamp;
detaching the first clamp from the hinge;
attaching a second clamp to the hinge; and
coupling a conically-shaped glass member to the second clamp.
22. The method of claim 21, wherein providing a case includes providing a wedge-style style case including one of an inside wedge-style case and an outside wedge-style case.
23. The method of claim 21, wherein detaching the first clamp from the hinge and attaching the second clamp to the hinge includes modifying a clamping angle from about 55 degrees relative to a vertical axis to between about 25 degrees and about 45 degrees relative to the vertical axis.
24. The method of claim 21, further comprising:
inserting a wedge at least partially within the second clamp; and
partially securing the conically-shaped glass member to the second clamp with the wedge.
25. The method of claim 21, further comprising aligning the case including the conically-shaped glass member with a case including a straight glass member.